Profile of gantenerumab and its potential in the treatment of Alzheimer's disease - Wikidata - awgldk - TriplyDB

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q27027675

about

Current Research Therapeutic Strategies for Alzheimer's Disease Treatment The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind.Amyloid beta: structure, biology and structure-based therapeutic development.Neurologically Potent Molecules from Crataegus oxyacantha; Isolation, Anticholinesterase Inhibition, and Molecular Docking Antibody Therapeutics Targeting Aβ and Tau.Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies

P2860

Q26765530-7B6FA462-B702-4CA6-9450-8237F9DA94FA Q38769710-0C4B98FA-992D-4C04-91BF-7377C2DC03DD Q39437881-9DEAAE2D-A246-4D08-A28D-D814963CA665 Q42021173-F9FF0697-BF91-49DD-855A-1CA7EB484DFE Q47591552-16073B1B-1FE6-4709-80C1-4A6B80AD46CA Q54982684-8A28B4D9-B886-4F43-B1B4-97ED537733E8 Q56524125-15DC9149-7ADA-4174-9501-7E17AB6D0198

P2860

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q27027675

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@ast

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@en

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@nl

type

label

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@ast

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@en

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@nl

prefLabel

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@ast

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@en

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@nl

P1433

Q27027675-F2AEB93E-BA12-4DAF-92AD-1C4963BE3C03

P1476

Q27027675-C12E165B-3ED5-4B6C-A719-D0A0E460676A

P2093

Q27027675-0B981A27-59CB-4CDC-A554-23AB89DB112A

Q27027675-70ABFE7E-E845-4A38-825F-7BD9B7B9DA84

Q27027675-A1E6767D-6DA7-4D2B-A6B8-8D949218FF1D

Q27027675-E6BB1890-49AC-429C-8BC3-8945FC6B070E

P275

Q27027675-D31A9033-B327-4118-A732-5903814B8B01

P2860

Q27027675-045A817B-533A-441D-ABCA-6320D6949744

Q27027675-07F38BBF-29FE-477D-8FDA-29BE9AC420F9

Q27027675-0854FE82-2407-4DCD-9453-01CF28C3AA3F

Q27027675-0877C423-21F4-4CC5-A5C1-B15A5176BE94

Q27027675-1B71B4A9-6D8E-4CAF-BAD9-CD96087AFC92

Q27027675-1FF783F1-09C2-416B-A410-AA4314BBF588

Q27027675-257AA7AC-5478-4414-BF72-A06FEDFA85D2

Q27027675-2BDE093F-3376-4860-A16C-F70CEB788A22

Q27027675-2BE88450-6362-45A9-9939-0B6090C97CE8

Q27027675-2D5D1326-C5DA-4AC8-8ECD-0D71309234C5

P304

Q27027675-68BFD090-F4C7-45E7-B76E-A4F382464767

P31

Q27027675-9F03A997-0234-48EE-A924-950F5A4DD0E2

P356

Q27027675-7262A8DE-6F45-470F-94C2-38B922CC4912

P407

Q27027675-98926505-9A47-4FDE-8785-716E7883532B

P478

Q27027675-ECAFEECD-A027-4719-8A89-F3B6412AD275

P50

Q27027675-06A90D25-4C49-4827-9E46-9C7FB3863514

Q27027675-64CF7E85-5C88-4760-B200-A473AF842034

Q27027675-90797B7A-1E2B-4624-80FC-1E3892BBA06A

Q27027675-9A15CC3C-B13A-4E9A-97D0-768EA9E00034

Q27027675-ACF5C499-237B-4FD8-8804-8047555CF69B

Q27027675-FAB09925-389B-42F8-AF89-4F24874133F2

P5008

Q27027675-3FF9CFDD-311F-4628-B83F-1630D3B406A8

P577

Q27027675-AECD5555-ED50-4D35-BD5A-365642B210F7

P698

Q27027675-ACE7B74B-866C-4CB6-894E-4FD27DE3D80C

P921

Q27027675-1D43B78F-0612-44A5-8969-5F48A6748925

Q27027675-6F6857E0-0EDF-46D2-831A-C861497668CD

Q27027675-70FD409A-D91D-417D-BB9F-4DA8AA341428

Q27027675-898E6DE5-C012-4C1E-855E-57137575BF9B

Q27027675-8B6E8018-5086-4B46-A02C-CB03AC067BD7

Q27027675-A60F7A10-AB67-45E0-A48D-B6F8CC42E8F0

P932

Q27027675-4638999B-9392-40F5-BE6F-92BF0FEC6309

P356

P1433

Drug Design, Development and Therapy

P1476

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

@en

P2093

Alessandra Caruso

http://www.w3.org/2001/XMLSchema#string

Dijana Novakovic

http://www.w3.org/2001/XMLSchema#string

Marco Feligioni

http://www.w3.org/2001/XMLSchema#string

Sergio Scaccianoce

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

ACET is a highly potent and specific kainate receptor antagonist: Characterisation and effects on hippocampal mossy fibre function

Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation

Na+ -Ca2+ exchanger (NCX3) knock-out mice display an impairment in hippocampal long-term potentiation and spatial learning and memory

Alzheimer's disease is a synaptic failure

A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro.

A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro.

Clearing the brain's amyloid cobwebs.

P304

1359-1364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S53401

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Nicola B. Mercuri

Ferdinando Nicoletti

Chiara Schepisi

Francesco Errico

P5008

P577

2013-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24255592

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

monoclonal antibody

membrane proteins

P932

3832388

http://www.w3.org/2001/XMLSchema#string